These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis. de Souza CF; Xander P; Monteiro AC; Silva AG; da Silva DC; Mai S; Bernardo V; Lopes JD; Jasiulionis MG PLoS One; 2012; 7(9):e44800. PubMed ID: 22984562 [TBL] [Abstract][Full Text] [Related]
3. Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation? Gilhooly EM; Morse-Gaudio M; Bianchi L; Reinhart L; Rose DP; Connolly JM; Reed JA; Albino AP Melanoma Res; 2001 Aug; 11(4):355-69. PubMed ID: 11479424 [TBL] [Abstract][Full Text] [Related]
4. miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. Mueller DW; Rehli M; Bosserhoff AK J Invest Dermatol; 2009 Jul; 129(7):1740-51. PubMed ID: 19212343 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression. Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354 [TBL] [Abstract][Full Text] [Related]
7. The E3 ligase APC/C(Cdh1) promotes ubiquitylation-mediated proteolysis of PAX3 to suppress melanocyte proliferation and melanoma growth. Cao J; Dai X; Wan L; Wang H; Zhang J; Goff PS; Sviderskaya EV; Xuan Z; Xu Z; Xu X; Hinds P; Flaherty KT; Faller DV; Goding CR; Wang Y; Wei W; Cui R Sci Signal; 2015 Sep; 8(392):ra87. PubMed ID: 26329581 [TBL] [Abstract][Full Text] [Related]
8. Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchymal transition, and metastasis. Azevedo H; Pessoa GC; de Luna Vitorino FN; Nsengimana J; Newton-Bishop J; Reis EM; da Cunha JPC; Jasiulionis MG Clin Epigenetics; 2020 Aug; 12(1):127. PubMed ID: 32831131 [TBL] [Abstract][Full Text] [Related]
9. Identifying mRNA, microRNA and protein profiles of melanoma exosomes. Xiao D; Ohlendorf J; Chen Y; Taylor DD; Rai SN; Waigel S; Zacharias W; Hao H; McMasters KM PLoS One; 2012; 7(10):e46874. PubMed ID: 23056502 [TBL] [Abstract][Full Text] [Related]
10. A gene expression signature of invasive potential in metastatic melanoma cells. Jeffs AR; Glover AC; Slobbe LJ; Wang L; He S; Hazlett JA; Awasthi A; Woolley AG; Marshall ES; Joseph WR; Print CG; Baguley BC; Eccles MR PLoS One; 2009 Dec; 4(12):e8461. PubMed ID: 20041153 [TBL] [Abstract][Full Text] [Related]
11. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis. Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485 [TBL] [Abstract][Full Text] [Related]
12. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma. Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388 [TBL] [Abstract][Full Text] [Related]
13. 'Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma'. Orgaz JL; Ladhani O; Hoek KS; Fernández-Barral A; Mihic D; Aguilera O; Seftor EA; Bernad A; Rodríguez-Peralto JL; Hendrix MJ; Volpert OV; Jiménez B Oncogene; 2009 Nov; 28(47):4147-61. PubMed ID: 19767774 [TBL] [Abstract][Full Text] [Related]
14. Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins. Teutschbein J; Haydn JM; Samans B; Krause M; Eilers M; Schartl M; Meierjohann S BMC Cancer; 2010 Jul; 10():386. PubMed ID: 20663135 [TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers. Bertucci F; Pages C; Finetti P; Rochaix P; Lamant L; Devilard E; Nguyen C; Houlgatte R; Birnbaum D; Xerri L; Brousset P Anticancer Res; 2007; 27(5A):3441-9. PubMed ID: 17970093 [TBL] [Abstract][Full Text] [Related]
16. HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome. Wardwell-Ozgo J; Dogruluk T; Gifford A; Zhang Y; Heffernan TP; van Doorn R; Creighton CJ; Chin L; Scott KL Oncogene; 2014 Feb; 33(8):1017-26. PubMed ID: 23435427 [TBL] [Abstract][Full Text] [Related]
17. Repression of genes involved in melanocyte differentiation in uveal melanoma. Bergeron MA; Champagne S; Gaudreault M; Deschambeault A; Landreville S Mol Vis; 2012; 18():1813-22. PubMed ID: 22815634 [TBL] [Abstract][Full Text] [Related]
18. Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo. Labelle-Côté M; Dusseault J; Ismaïl S; Picard-Cloutier A; Siegel PM; Larose L BMC Cancer; 2011 Oct; 11():443. PubMed ID: 21992144 [TBL] [Abstract][Full Text] [Related]
19. RT-qPCR analysis of human melanoma progression-related genes - A novel workflow for selection and validation of candidate reference genes. Janik ME; Szwed S; Grzmil P; Kaczmarek R; Czerwiński M; Hoja-Łukowicz D Int J Biochem Cell Biol; 2018 Aug; 101():12-18. PubMed ID: 29778526 [TBL] [Abstract][Full Text] [Related]
20. Systems analysis identifies miR-29b regulation of invasiveness in melanoma. Andrews MC; Cursons J; Hurley DG; Anaka M; Cebon JS; Behren A; Crampin EJ Mol Cancer; 2016 Nov; 15(1):72. PubMed ID: 27852308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]